[
    [
        {
            "time": "",
            "original_text": "明看并購 | 貝泰妮：「她經濟」的高票房",
            "features": {
                "keywords": [
                    "貝泰妮",
                    "她經濟",
                    "高票房"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消費",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "明看并購 | 貝泰妮：「她經濟」的高票房",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "「財富周評榜」「醫茅們」表現分化：邁瑞醫療市值漲304億，「女人的茅台」爱美客周跌超13%",
            "features": {
                "keywords": [
                    "醫茅",
                    "邁瑞醫療",
                    "愛美客",
                    "市值漲",
                    "周跌"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "醫美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "「財富周評榜」「醫茅們」表現分化：邁瑞醫療市值漲304億，「女人的茅台」爱美客周跌超13%",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "醫美概念股市集體拉升，悅心健康漲停",
            "features": {
                "keywords": [
                    "醫美",
                    "概念股",
                    "漲停"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "醫美概念股市集體拉升，悅心健康漲停",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "科創板蓄勢待發，中國生物製藥2020處於業績過渡期",
            "features": {
                "keywords": [
                    "科創板",
                    "中國生物製藥",
                    "業績過渡期"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科創板蓄勢待發，中國生物製藥2020處於業績過渡期",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "主力資金看好醫療服務板塊 機構搶籌次新股貝泰妮",
            "features": {
                "keywords": [
                    "主力資金",
                    "醫療服務",
                    "貝泰妮",
                    "機構搶籌"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "次新股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "主力資金看好醫療服務板塊 機構搶籌次新股貝泰妮",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]